RGEN
Repligen Corp
Price:  
130.19 
USD
Volume:  
757,950.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RGEN Relative Valuation

-107.9%
Upside

As of 2025-07-12, the Relative Valuation of Repligen Corp (RGEN) is (10.28) USD. This relative valuation is based on P/E multiples. With the latest stock price at 130.19 USD, the upside of Repligen Corp based on Relative Valuation is -107.9%.

The range of the Relative Valuation is (10.49) - (10.16) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 29.9x - 31.6x 30.1x
Forward P/E multiples 26.4x - 29.0x 28.6x
Fair Price (10.49) - (10.16) (10.28)
Upside -108.1% - -107.8% -107.9%
130.19 USD
Stock Price
(10.28) USD
Fair Price

RGEN Relative Valuation - Historical P/E Data

Date P/E
2025-07-11 -371.57
2025-07-10 -382.45
2025-07-09 -370.52
2025-07-08 -366.92
2025-07-07 -355.14
2025-07-03 -363.81
2025-07-02 -362.36
2025-07-01 -360.87
2025-06-30 -354.99
2025-06-27 -352.65
2025-06-26 -354.51
2025-06-25 -353.96
2025-06-24 -352.05
2025-06-23 -342.81
2025-06-20 -339.21
2025-06-18 -335.47
2025-06-17 -345.37
2025-06-16 -359.87
2025-06-13 -363.95
2025-06-12 -374.74
2025-06-11 -376.74
2025-06-10 -379.22
2025-06-09 -375.83
2025-06-06 -366.18
2025-06-05 -361.61
2025-06-04 -361.19
2025-06-03 -355.05
2025-06-02 -338.41
2025-05-30 -336.98
2025-05-29 -349.11
2025-05-28 -345.86
2025-05-27 -349.74
2025-05-23 -337.21
2025-05-22 -343.78
2025-05-21 -343.09
2025-05-20 -364.15
2025-05-19 -360.16
2025-05-16 -361.04
2025-05-15 -351.80
2025-05-14 -365.44
2025-05-13 -375.46
2025-05-12 -381.65
2025-05-09 -351.74
2025-05-08 -364.90
2025-05-07 -362.13
2025-05-06 -372.17
2025-05-05 -402.20
2025-05-02 -403.88
2025-05-01 -391.58
2025-04-30 -393.84